A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

New research links PSA and PSA density to long-term prostate cancer risk, supporting risk-adapted screening strategies. Learn more about the 20-year findings.

Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found. The finding suggests that PSAD may be an additional parameter that clinicians ...

Many men with low levels could be spared from invasive procedures and frequent testing ...

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...

Using MRI scans in screening for prostate cancer could detect tumours missed by prostate-specific antigen (PSA) blood testing alone, according to a major new study from University College London (UCL) ...

The REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 ...